Results 81 to 90 of about 66,385 (167)

Early risk identification for recurrent wheezing in children with respiratory syncytial virus infections. [PDF]

Am J Transl Res
Wang Y, Shi Y, Wang L.
europepmc   +1 more source

Epidemiology of moderate-to-severe respiratory syncytial virus infections in children in subtropical Okinawa, Japan: a 4-year retrospective study. [PDF]

Trop Med Health
Fukuoka-Araki K, Araki K, Fukuoka H, Cho Y, Matayoshi K, Makiya T, Kinjo S, Yamashiro T.   +7 more
europepmc   +1 more source

Genetic and Epidemiological Insights Into Respiratory Syncytial Virus Infections: A Comparative Study of Hospitalized Versus Community Cases in Portugal (2021-2023). [PDF]

Influenza Other Respir Viruses
Lança M, Gaio V, Rodrigues AP, Henriques C, Gomes L, Dias D, de Jesus Chasqueira M, Guiomar R, Melo A.   +8 more
europepmc   +1 more source

Estimated Incidence of All-Cause Respiratory Hospitalizations and Deaths Attributable to Respiratory Syncytial Virus Infections in Adults in Finland between 2011 and 2019: A Retrospective Database Study. [PDF]

J Epidemiol Glob Health
Bruyndonckx R, Polkowska-Kramek A, Liang C, Kosunen M, Hätinen OP, Esnaola M, Casas M, Peerawaranun P, Ewnetu WB, Gessner BD, Begier E.   +10 more
europepmc   +1 more source

Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections. [PDF]

NPJ Vaccines
Taquet M, Todd JA, Harrison PJ.
europepmc   +1 more source

Clinical progression parameters associated with SARS-CoV-2, influenza, and respiratory syncytial virus infections in a large US integrated healthcare population. [PDF]

PLoS Comput Biol
Parker NT, Hong V, Davis GS, Pomichowski M, Reyes IA, Xie F, Mueller NF, Rodriguez-Barraquer I, Tartof SY, Lewnard JA.   +9 more
europepmc   +1 more source

Global outbreaks of respiratory syncytial virus infections from 1960 to 2025: a systematic review and meta-analysis. [PDF]

EClinicalMedicine
Duan Q, Pan J, Zheng L, Jin Z, Li S, Zhang H, Fu X, Chen R, Yu Z, Qin S, Xu X, Chen Y, Sun J, Liu S.   +13 more
europepmc   +1 more source

Six-year epidemiological dynamics of human respiratory syncytial virus infections in children in central China (2019-2024): pandemic suppression, 2023 resurgence, and immune debt effect. [PDF]

Front Cell Infect Microbiol
Xia Z, Li X, Shen A, Mokrousov I, Guo P, Zhang Y.   +5 more
europepmc   +1 more source

Estimated Incidence of Hospitalisations and Deaths Attributable to Respiratory Syncytial Virus Infections in Adults in Norway between 2010 and 2019: A Time-Series Modelling Study. [PDF]

J Epidemiol Glob Health
Casas M, Liang C, Molden T, Bruyndonckx R, Esnaola M, Basu S, Ewnetu WB, Peerawaranun P, Moges SM, Gessner BD, Polkowska-Kramek A, Begier E.   +11 more
europepmc   +1 more source

Estimating the economically justifiable price of nirsevimab versus standard of practice for the prevention of respiratory syncytial virus infections in neonates and infants in Spain: a cost-utility modelling study. [PDF]

BMJ Public Health
Gil-Prieto R, Pérez-Martín J, Díaz Aguiló A, Soudani S, Platero-Alonso L, López-Belmonte JL, de la Cuadra-Grande A, Casado MÁ, Álvarez Aldean J.   +8 more
europepmc   +1 more source